Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial

BACKGROUND: The DATA study evaluated the use of two different durations of anastrozole in patients with hormone receptor-positive breast cancer who were disease-free after 2–3 years of tamoxifen. We hereby present the follow-up analysis, which was performed after all patients reached a minimum follo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tjan-Heijnen, Vivianne C.G., Lammers, Senna W.M., Geurts, Sandra M.E., Vriens, Ingeborg J.H., Swinkels, Astrid C.P., Smorenburg, Carolien H., van der Sangen, Maurice J.C., Kroep, Judith R., de Graaf, Hiltje, Honkoop, Aafke H., Erdkamp, Frans L.G., de Roos, Wilfred K., Linn, Sabine C., Imholz, Alexander L.T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041456/
https://www.ncbi.nlm.nih.gov/pubmed/36992863
http://dx.doi.org/10.1016/j.eclinm.2023.101901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041456/
https://www.ncbi.nlm.nih.gov/pubmed/36992863
http://dx.doi.org/10.1016/j.eclinm.2023.101901

Ejemplares similares